Neurodegenerative disease
MONDO:0005559A disorder of the central nervous system characterized by gradual and progressive loss of neural tissue and neurologic function.
Also known as: degenerative disease, brain degeneration, central nervous system degenerative disorder, central nervous system neurodegenerative disorder, degenerative disorder of central nervous system, cerebral degeneration disease
3277 clinical trials for this condition and its sub-types, 186 tagged with Neurodegenerative disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Neurodegenerative disease
-
Tauopathy 24 trials · 1,190 incl. sub-types
2 sub-types
- Alzheimer disease 1,184 trials Sub-types →
- Argyrophilic grain disease 0 trials
-
Demyelinating disease 27 trials · 931 incl. sub-types
8 sub-types
- Demyelinating disease of central nervous system 4 trials · 860 incl. sub-types Sub-types →
- Polyradiculoneuropathy 1 trial · 64 incl. sub-types Sub-types →
- Demyelinating polyneuropathy 2 trials · 62 incl. sub-types Sub-types →
- Acute disseminated encephalomyelitis 7 trials · 8 incl. sub-types Sub-types →
- Central pontine myelinolysis 2 trials
- Balo concentric sclerosis 0 trials
- Schilder disease 0 trials
- Boylan dew greco syndrome 0 trials
-
Inherited neurodegenerative disorder 10 trials · 807 incl. sub-types
82 sub-types
- Frontotemporal dementia 132 trials · 178 incl. sub-types Sub-types →
- Hereditary motor neuron disease 1 trial · 169 incl. sub-types Sub-types →
- Hereditary cerebellar ataxia 0 trials · 116 incl. sub-types Sub-types →
- Huntington disease and related disorders 0 trials · 91 incl. sub-types Sub-types →
- Progressive supranuclear palsy 73 trials · 77 incl. sub-types Sub-types →
- Leukodystrophy 6 trials · 72 incl. sub-types Sub-types →
- Familial Alzheimer disease 13 trials · 55 incl. sub-types Sub-types →
- Hereditary spastic paraplegia 27 trials · 33 incl. sub-types Sub-types →
- Hereditary optic atrophy 6 trials · 23 incl. sub-types Sub-types →
- Neuronal ceroid lipofuscinosis 6 trials · 23 incl. sub-types Sub-types →
- GM2 gangliosidosis 14 trials · 19 incl. sub-types Sub-types →
- Kennedy disease 19 trials
- Corticobasal syndrome 19 trials
- Frontotemporal dementia with motor neuron disease 13 trials · 19 incl. sub-types Sub-types →
- Posterior cortical atrophy 11 trials
- Chediak-Higashi syndrome 9 trials
- Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types Sub-types →
- APP-related brain and vascular amyloidosis 0 trials · 5 incl. sub-types Sub-types →
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 0 trials · 5 incl. sub-types Sub-types →
- Inherited Creutzfeldt-Jakob disease 5 trials
- TUBB4A-related neurologic disorder 4 trials Sub-types →
- Fatal familial insomnia 4 trials
- Mitochondrial DNA depletion syndrome 4a 3 trials
- Alzheimer disease 17 1 trial
- Alzheimer disease 18 1 trial
- Ataxia-telangiectasia-like disorder 1 trial Sub-types →
- Developmental and epileptic encephalopathy, 35 1 trial
- Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures 1 trial
- Neurodegenerative syndrome due to cerebral folate transport deficiency 1 trial
- Neuronal intranuclear inclusion disease 1 trial
- Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 1 trial
- DCTN1-related neurodegeneration 0 trials Sub-types →
- Huntington disease-like 1 0 trials
- Huntington disease-like 2 0 trials
- ITM2B amyloidosis 0 trials Sub-types →
- PEHO syndrome 0 trials
- PRKAR1B-related neurodegenerative dementia with intermediate filaments 0 trials
- X-linked neurodegenerative syndrome, Bertini type 0 trials
- X-linked neurodegenerative syndrome, Hamel type 0 trials
- Agenesis of the corpus callosum with peripheral neuropathy 0 trials
- Amyotrophic lateral sclerosis-parkinsonism-dementia complex 0 trials
- Angioid streaks of choroid 0 trials
- Attenuated Chédiak-Higashi syndrome 0 trials
- Autosomal recessive cerebral atrophy 0 trials
- Boylan dew greco syndrome 0 trials
- Cerebellar ataxia-hypogonadism syndrome 0 trials Sub-types →
- Cerebral sclerosis similar to Pelizaeus-Merzbacher disease 0 trials
- Combined oxidative phosphorylation deficiency 29 0 trials
- Deafness dystonia syndrome 0 trials
- Diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0 trials
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0 trials
- Early-childhood-onset neurodegeneration with retinitis pigmentosa, sensorineural hearing loss, and demyelinating peripheral neuropathy 0 trials
- Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 0 trials
- Encephalopathy due to beta-mercaptolactate-cysteine disulfiduria 0 trials
- Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy 0 trials Sub-types →
- Facial onset sensory and motor neuronopathy 0 trials
- Fatal post-viral neurodegenerative disorder 0 trials
- Ferro-cerebro-cutaneous syndrome 0 trials
- Hereditary sensory neuropathy-deafness-dementia syndrome 0 trials
- Hypotonia, infantile, with psychomotor retardation and characteristic facies 0 trials Sub-types →
- Infantile cerebellar-retinal degeneration 0 trials
- Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome 0 trials
- Microphthalmia-brain atrophy syndrome 0 trials
- Myoclonic cerebellar dyssynergia 0 trials
- Neurodegeneration and seizures due to copper transport defect 0 trials
- Neurodegeneration with ataxia and late-onset optic atrophy 0 trials
- Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset 0 trials
- Neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities 0 trials
- Neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline 0 trials
- Neurodegeneration, childhood-onset, with cerebellar ataxia and cognitive decline 0 trials
- Neurodegeneration, childhood-onset, with cerebellar atrophy 0 trials
- Neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0 trials
- Neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 0 trials
- Neurodegeneration, childhood-onset, with progressive microcephaly 0 trials
- Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia 0 trials
- Neurodegeneration, infantile-onset, biotin-responsive 0 trials
- Neurodegenerative disorder with cerebellar and caudate atrophy 0 trials
- Neurodegenerative disorder, X-linked, female-restricted, with parkinsonism and cognitive impairment 0 trials
- Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome 0 trials
- Radiation sensitivity/chromosome instability syndrome, autosomal dominant 0 trials
- Severe neurodegenerative syndrome with lipodystrophy 0 trials
- Striatonigral degeneration 0 trials Sub-types →
-
Motor neuron disorder 69 trials · 506 incl. sub-types
4 sub-types
- Amyotrophic lateral sclerosis 327 trials · 341 incl. sub-types Sub-types →
- Hereditary motor neuron disease 1 trial · 169 incl. sub-types Sub-types →
- Acquired motor neuron disease 0 trials · 39 incl. sub-types Sub-types →
- Madras motor neuron disease 0 trials
-
Synucleinopathy 18 trials · 237 incl. sub-types
2 sub-types
- Lewy body dementia 130 trials
- Multiple system atrophy 110 trials · 119 incl. sub-types Sub-types →
-
Cerebellar degeneration 6 trials · 150 incl. sub-types
2 sub-types
- Cerebellar ataxia 40 trials · 144 incl. sub-types Sub-types →
- Paraneoplastic cerebellar degeneration 1 trial
-
Primary progressive aphasia 42 trials · 71 incl. sub-types
2 sub-types
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusions 6 trials · 47 incl. sub-types Sub-types →
- Logopenic progressive aphasia 15 trials
-
Cerebral degeneration 0 trials · 61 incl. sub-types
2 sub-types
- Pick disease 35 trials
- Corticobasal degeneration disorder 28 trials
-
Secondary Parkinson disease 9 trials
1 sub-type
- Postencephalitic Parkinson disease 0 trials
-
Neuroaxonal dystrophy 1 trial · 9 incl. sub-types
2 sub-types
- Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types Sub-types →
- Neuroaxonal dystrophy renal tubular acidosis 0 trials
-
Marchiafava-Bignami disease 1 trial
-
Human prion disease 1 trial
4 sub-types
- Acquired human prion disease 0 trials
- Kuru 0 trials
- Sporadic fatal insomnia 0 trials
- Variably protease-sensitive prionopathy 0 trials
-
Brachial amyotrophic diplegia 0 trials
-
Choroidal sclerosis 0 trials
4 sub-types
- Angioid streaks of choroid 0 trials
- Diffuse secondary choroid atrophy 0 trials
- Hereditary choroidal atrophy 0 trials Sub-types →
- Senile atrophy of choroid 0 trials
-
Eyelid degenerative disorder 0 trials
-
Hypertrophic olivary degeneration 0 trials
-
2 sub-types
-
Olivopontocerebellar atrophy 0 trials
-
Primary progressive freezing gait 0 trials
-
Senile degeneration of brain 0 trials
-
Superficial siderosis 0 trials
Most studied deeper sub-types
-
Alzheimer's drug ALZ-801 tested Long-Term in High-Risk group
Disease control Stopped earlyThis study looked at the long-term safety and effects of ALZ-801, a tablet taken twice daily, in 163 people with early Alzheimer's disease who have the APOE4/4 gene. Participants had already completed a previous phase 3 study. The goal was to see if the drug could slow cognitive …
Phase 3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Alzheimer's drug trial halted early: what happened?
Disease control Stopped earlyThis early-stage study tested a new drug, ADEL-Y01, in healthy volunteers and people with mild Alzheimer's or mild cognitive impairment. The goal was to check safety and how the drug moves through the body. The trial was stopped early, so results are limited.
Phase 1 • Sponsor: Alzheimer's Disease Expert Lab (ADEL), Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Alzheimer's drug extension trial halted early — what we know
Disease control Stopped earlyThis study gave Alzheimer's patients who had already completed earlier XPro1595 trials an extra 55 to 74 weeks of the drug to check long-term safety and effects on memory and brain health. Only 11 people took part, and the trial was terminated early, so the findings are limited. …
Phase 2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Neurodegenerative drug study ends early after only 17 participants
Disease control Stopped earlyThis study was designed to let people who had already taken latozinemab in an earlier study continue receiving the drug. Only 17 people took part, and the study was stopped early. The goal was to track safety and how long people stayed on treatment, not to test if the drug could …
Phase 3 • Sponsor: Alector Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Experimental drug aims to curb disinhibition in dementia patients
Symptom relief Stopped earlyThis study tested a drug called AVP-786 to see if it could safely reduce disinhibition—impulsive or inappropriate behavior—in people with neurodegenerative disorders like Alzheimer's or frontotemporal dementia. The trial planned to include many participants but was terminated ear…
Phase 2 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Spine treatment data collection ends early
Knowledge-focused Stopped earlyThis study was a registry that collected information from over 900 adults being treated for degenerative spine conditions. Researchers focused on the use of bone graft materials and how patients felt after treatment. The study did not test any new treatment and was stopped early.
Sponsor: AO Innovation Translation Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC